Associated Papers
MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study.
Cai X et al.
Bmc Cancer, 2024
39528978 (PubMed )
Supplement: 12885_2024_13163_MOESM1_ESM.xlsx › SNVs
Systematic review and meta-analysis of genomic alterations in acral melanoma.
Broit N et al.
Pigment Cell & Melanoma Research, 2022
35229492 (PubMed )
Supplement: PCMR-35-369-s002.pdf
Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report.
Toscano de Mendonça UB et al.
Oncotarget, 2018
Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.
Moon KR et al.
The Journal of Investigative Dermatology, 2018
A Novel KIT INDEL Mutation in Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1.
Lee JH et al.
Annals of Laboratory Medicine, 2016
Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06).
Lee SJ et al.
The Oncologist, 2015
Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome.
Gustafson SA et al.
American Journal of Clinical Pathology, 2009
Select a paper to view details